2008 Annual Meeting

Charting the Course – New Passages to Protecting the Public Health

104th Annual Meeting
May 17-20, 2008
Baltimore, MD

2008 NABP Annual Meeting Continuing Pharmacy Education Sessions

The following presentations were shown at the NABP 104th Annual Meeting in May 2008:
 

Teen Addiction – Prescription Medications: The New Heroin?

According to statistics, teen addiction to prescription pain medications is reaching catastrophic proportions. Meeting participants will review the issues associated with this problem, including sources of prescription drugs, the role the Internet plays, and strategies to assist in abuse prevention.

• Thomas A. Hedrick, Jr, BA, Senior Communications Officer and Founding Member, Partnership for a Drug-Free America
• Barbara Delaney, MBA, Director of Research, Partnership for a Drug-Free America
• Phil Bauer, Member, Parent Advisory Board, Partnership for a Drug-Free America
  Parents, Kids and Drugs. Today’s Changing Landscape in Substance Abuse: Adolescent Abuse of Rx & OTC Medicines
  
  

Legislative and Regulatory Update

Boards of pharmacy are continually faced with an assortment of legislative and regulatory issues. During this session, participants will review recent federal and state legislative and regulatory initiatives of interest to boards of pharmacy.

• Joshua M. Bolin, BA, State Relations Manager, NABP
  State Regulatory Update

• Eileen Lewalski, PharmD, JD, Professional Affairs Manager, NABP
  Federal Regulatory Update
  
  

Pedigree Update: RFID and Diversion from Common Carriers

As counterfeit drugs and devices and diversion continue to pose significant threats to the public health, the use of electronic tools is becoming increasingly common to counter this threat, as well as to optimize the efficiency and effectiveness of the drug distribution process. During this session, meeting participants will examine how industry and enforcement officials have incorporated such tools into their efforts.

• Ryan Toole, Supervisory Special Agent, Federal Bureau of Investigation
  FBI Activities and Pharmaceutical Crime

• Ilisa Bernstein, PharmD, JD, Director of Pharmacy Affairs, Food and Drug Administration
  Pedigree Update: RFID and Diversion
  
  

Medicaid Fraud: Tamper-Resistant Prescription Pads and Beyond

Centers for Medicare and Medicaid Services (CMS) representatives will discuss Congress’s findings pertaining to fraudulent activities in pharmacy and its efforts to combat such activities, as well as how boards of pharmacy may work with CMS in these efforts.

• Jason Weinstock, JD, Law Enforcement Coordinator, Centers for Medicare and Medicaid Services, Medicaid Integrity Group
  An Overview of CMS’ Medicaid Integrity Program and An Update on the Implementation of the Tamper Resistant Prescription Paper Law

• Michael A. Burleson, RPh, Executive Director, Kentucky Board of Pharmacy
  Kentucky Medicaid Tamper-Resistant Prescription Pad
  
  

Case Strategy: How to Investigate an Internet Pharmacy

Relentless solicitation efforts of an increasing number of rogue Internet “pharmacy” sites are placing the public health at risk. State boards of pharmacy, other state agencies, and the federal government must work together to put these sites out of business. During this session, meeting participants will examine and discuss strategies to build a case against an Internet pharmacy using all available resources.

• Benjamin N. Gluck, MA, JD, Partner and Shareholder, Bird, Marella, Boxer, Wolpert, Nessim, Drooks, and Lincenberg, A Professional Corporation
  Case Strategy: How to Investigate an Internet Pharmacy
  
  

Compounding Update: Where is USP 797?

Meeting participants will examine the recent updates to the United States Pharmacopeia Chapter 797 sterile compounding standards.

• Claudia C. Okeke, PhD, RPh, Scientific Fellow, United States Pharmacopeia
  USP Chapter <797>: Update on Recent Revisions

• Ruth K. Miller, JD, Senior Counsel, United States Pharmacopeia
  USP General Chapter <797>: Legal/Regulatory Update